Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Haynes

Showing results (151-160 of 222) with videos related to

Pageof 23
Sort By:
Journal of Viral Hepatitis|March 13, 2012
Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort studyK A Forde, K Haynes, A B Troxel, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|October 8, 1999
Simultaneous determination of artemether and its major metabolite dihydroartemisinin in plasma by gas chromatography-mass spectrometry-selected ion monitoringS S Mohamed, S A Khalid, S A Ward, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 19, 2020
Human parainfluenza virus circulation, United States, 2011-2019Nicholas P DeGroote, Amber K Haynes, Calli Taylor, et al.
Genes and Immunity|June 17, 2017
Epigenetic and gene expression analysis of ankylosing spondylitis-associated loci implicate immune cells and the gut in the disease pathogenesisZ Li, K Haynes, D J Pennisi, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
A Drug Repurposing Approach for Antimalarials Interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and Human Angiotensin-Converting Enzyme 2 (ACE2)Paolo Coghi, Li Jun Yang, Jerome P L Ng, et al.
Plos Pathogens|January 9, 2015
Environmental drivers of the spatiotemporal dynamics of respiratory syncytial virus in the United StatesVirginia E Pitzer, Cécile Viboud, Wladimir J Alonso, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2008
First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisoneJohannes Nagelschmitz, Barbara Voith, Georg Wensing, et al.
The Journal of Antimicrobial Chemotherapy|July 21, 2019
Development of pyridyl thiosemicarbazones as highly potent agents for the treatment of malaria after oral administrationChristopher J Parkinson, Geoffrey W Birrell, Marina Chavchich, et al.
Chemmedchem|September 5, 2007
The Fe2+-mediated decomposition, PfATP6 binding, and antimalarial activities of artemisone and other artemisinins: the unlikelihood of C-centered radicals as bioactive intermediatesRichard K Haynes, Wing Chi Chan, Chung-Man Lung, et al.
International Journal of Antimicrobial Agents|September 3, 2018
Corrigendum to 'In vitro activity of artemisone and artemisinin derivatives against extracellular and intracellular Helicobacter pylori' [International Journal of Antimicrobial Agents 48/1 (2016) 101-105]Francesca Sisto, Maria Maddalena Scaltrito, Carla Masia, et al.
Pageof 23

Showing results (151-160 of 222) with videos related to

Sort By:
Pageof 23
Journal of Viral Hepatitis|March 13, 2012
Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort studyK A Forde, K Haynes, A B Troxel, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|October 8, 1999
Simultaneous determination of artemether and its major metabolite dihydroartemisinin in plasma by gas chromatography-mass spectrometry-selected ion monitoringS S Mohamed, S A Khalid, S A Ward, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 19, 2020
Human parainfluenza virus circulation, United States, 2011-2019Nicholas P DeGroote, Amber K Haynes, Calli Taylor, et al.
Genes and Immunity|June 17, 2017
Epigenetic and gene expression analysis of ankylosing spondylitis-associated loci implicate immune cells and the gut in the disease pathogenesisZ Li, K Haynes, D J Pennisi, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
A Drug Repurposing Approach for Antimalarials Interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and Human Angiotensin-Converting Enzyme 2 (ACE2)Paolo Coghi, Li Jun Yang, Jerome P L Ng, et al.
Plos Pathogens|January 9, 2015
Environmental drivers of the spatiotemporal dynamics of respiratory syncytial virus in the United StatesVirginia E Pitzer, Cécile Viboud, Wladimir J Alonso, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2008
First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisoneJohannes Nagelschmitz, Barbara Voith, Georg Wensing, et al.
The Journal of Antimicrobial Chemotherapy|July 21, 2019
Development of pyridyl thiosemicarbazones as highly potent agents for the treatment of malaria after oral administrationChristopher J Parkinson, Geoffrey W Birrell, Marina Chavchich, et al.
Chemmedchem|September 5, 2007
The Fe2+-mediated decomposition, PfATP6 binding, and antimalarial activities of artemisone and other artemisinins: the unlikelihood of C-centered radicals as bioactive intermediatesRichard K Haynes, Wing Chi Chan, Chung-Man Lung, et al.
International Journal of Antimicrobial Agents|September 3, 2018
Corrigendum to 'In vitro activity of artemisone and artemisinin derivatives against extracellular and intracellular Helicobacter pylori' [International Journal of Antimicrobial Agents 48/1 (2016) 101-105]Francesca Sisto, Maria Maddalena Scaltrito, Carla Masia, et al.
Pageof 23